Impax Asset Management Group’s Boston Scientific BSX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$85.3M	Sell	1,359,572 -364,355	-21%	-$29.1M	0.59%	47
2025 Q4	$164M	Sell	1,723,927 -3,453	-0.2%	-$339K	1.03%	32
2025 Q3	$169M	Buy	1,727,380 +277,644	+19%	+$28.8M	0.98%	34
2025 Q2	$154M	Sell	1,449,736 -15,034	-1%	-$1.52M	0.89%	40
2025 Q1	$146M	Sell	1,464,770 -3,040,709	-67%	-$306M	0.88%	40
2024 Q4	$401M	Sell	4,505,479 -964,695	-18%	-$84.9M	1.82%	13
2024 Q3	$457M	Buy	5,470,174 +815,403	+18%	+$64.3M	1.8%	12
2024 Q2	$358M	Buy	4,654,771 +189,705	+4%	+$13.9M	1.46%	16
2024 Q1	$305M	Buy	4,465,066 +123,021	+3%	+$7.91M	1.17%	27
2023 Q4	$250M	Buy	4,342,045 +80,071	+2%	+$4.27M	1.01%	32
2023 Q3	$225M	Sell	4,261,974 -1,774,667	-29%	-$93.1M	1%	31
2023 Q2	$326M	Sell	6,036,641 -941,770	-13%	-$49.2M	1.31%	22
2023 Q1	$348M	Sell	6,978,411 -45,023	-0.6%	-$2.12M	1.46%	16
2022 Q4	$324M	Buy	7,023,434 +402,301	+6%	+$17.4M	1.45%	17
2022 Q3	$256M	Buy	6,621,133 +2,132,468	+48%	+$85.5M	1.32%	20
2022 Q2	$167M	Buy	+4,488,665	New	+$183M	0.82%	47